| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50090-6268-0 | 50090-6268 | HUMAN PRESCRIPTION DRUG | PIFELTRO | doravirine | TABLET, FILM COATED | ORAL | 20221213 | N/A | NDA | NDA210806 | A-S Medication Solutions | DORAVIRINE | 100 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-6268-0) |
| 0006-3069-01 | 0006-3069 | HUMAN PRESCRIPTION DRUG | PIFELTRO | doravirine | TABLET, FILM COATED | ORAL | 20180720 | N/A | NDA | NDA210806 | Merck Sharp & Dohme LLC | DORAVIRINE | 100 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (0006-3069-01) |
| 50090-6237-0 | 50090-6237 | HUMAN PRESCRIPTION DRUG | PIFELTRO | doravirine | TABLET, FILM COATED | ORAL | 20221121 | N/A | NDA | NDA210806 | A-S Medication Solutions | DORAVIRINE | 100 mg/1 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-6237-0) |